Sodium Citrate w/v Anticoagulant
Active substance: trisodium citrate
INJECTION, SOLUTION · TRISODIUM CITRATE DIHYDRATE 4 g/100mL
United StatesActive
Marketing holder: Terumo BCT, Ltd
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TRISODIUM CITRATE DIHYDRATE · 4 g/100mL
Registration
- Registration number
- 14537-883
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 14537-883 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 14537-883 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 14537-883 · Verified 2026-10-09 · open in source